title: Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism.
authors.affiliation: Department of Cardiologic, Thoracic, and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua Medical School, Padua, Italy.
authors.forename: C M
authors.initials: CM
authors.lastname: Radu
authors.forename: L
authors.initials: L
authors.lastname: Spiezia
authors.forename: E
authors.initials: E
authors.lastname: Campello
authors.forename: S
authors.initials: S
authors.lastname: Gavasso
authors.forename: B
authors.initials: B
authors.lastname: Woodhams
authors.forename: P
authors.initials: P
authors.lastname: Simioni
mesh_terms: D000368:Aged; D025901:Carboxypeptidase B2 / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood*; D013917:Thrombin / Q000378:metabolism; D013927:Thrombosis / Q000097:blood; D054556:Venous Thromboembolism / Q000097:blood*
chemical_list: D025901:Carboxypeptidase B2; D013917:Thrombin